Climate Change Data Portal
DOI | 10.1126/science.abb4489 |
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease | |
Dai W.; Zhang B.; Jiang X.-M.; Su H.; Li J.; Zhao Y.; Xie X.; Jin Z.; Peng J.; Liu F.; Li C.; Li Y.; Bai F.; Wang H.; Cheng X.; Cen X.; Hu S.; Yang X.; Wang J.; Liu X.; Xiao G.; Jiang H.; Rao Z.; Zhang L.-K.; Xu Y.; Yang H.; Liu H. | |
发表日期 | 2020 |
ISSN | 0036-8075 |
起始页码 | 1331 |
结束页码 | 1335 |
卷号 | 368期号:6497 |
英文摘要 | SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the etiological agent responsible for the global COVID-19 (coronavirus disease 2019) outbreak. The main protease of SARS-CoV-2, Mpro, is a key enzyme that plays a pivotal role in mediating viral replication and transcription. We designed and synthesized two lead compounds (11a and 11b) targeting Mpro. Both exhibited excellent inhibitory activity and potent anti-SARS-CoV-2 infection activity. The x-ray crystal structures of SARS-CoV-2 Mpro in complex with 11a or 11b, both determined at a resolution of 1.5 angstroms, showed that the aldehyde groups of 11a and 11b are covalently bound to cysteine 145 of Mpro. Both compounds showed good pharmacokinetic properties in vivo, and 11a also exhibited low toxicity, which suggests that these compounds are promising drug candidates. © 2020 American Association for the Advancement of Science. All rights reserved. |
关键词 | aldehydeantimicrobial activitydrugenzyme activityinfectivityinhibitorreaction kineticsviral diseaseCoronavirusSARS coronavirus3C-like proteinase, Coronavirusantivirus agentcysteine proteinaseviral proteinanimalBetacoronaviruschemical structurechemistryChlorocebus aethiopsCoronavirus infectiondogdrug designdrug effectenzyme active siteenzymologyfemalehumanmalemousepandemicpreclinical studyprotein tertiary structureSprague Dawley rattoxicity testingVero cell linevirus pneumoniaAnimalsAntiviral AgentsBetacoronavirusCatalytic DomainChlorocebus aethiopsCoronavirus InfectionsCysteine EndopeptidasesDogsDrug DesignDrug Evaluation, PreclinicalFemaleHumansMaleMiceMolecular StructurePandemicsPneumonia, ViralProtein Structure, TertiaryRats, Sprague-DawleyToxicity TestsVero CellsViral Nonstructural Proteins |
语种 | 英语 |
来源机构 | Science |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/133422 |
推荐引用方式 GB/T 7714 | Dai W.,Zhang B.,Jiang X.-M.,et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease[J]. Science,2020,368(6497). |
APA | Dai W..,Zhang B..,Jiang X.-M..,Su H..,Li J..,...&Liu H..(2020).Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.,368(6497). |
MLA | Dai W.,et al."Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease".368.6497(2020). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。